Using the GEO dataset, we found that the expression of MEOX2 presented an increasing trend both when breast cancer patients were treated with anti-tumor drugs and when breast cancer cells were treated with anti-carcinogenic compounds.
← all excerpts
A Crucial Angiogenesis-Associated Gene MEOX2 Could Be a Promising Biomarker Candidate for Breast Cancer.
1
—
—